Atlas Arteria (ASX:ALX) share price jumps after net profit soars 800%

Atlas Arteria shares are on the move due to a strong first half performance.

| More on:
interchanging highways with light traffic

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Atlas Arteria Ltd (ASX: ALX) share price has stepped into the green on Thursday as the toll-road developer reported its FY21 half-year results.

Atlas shares are currently changing hands at $6.38 apiece, a 1.83% jump on the day.

Let's investigate further.

Atlas Arteria share price climbs on strong profit and recovery in road traffic volumes

  • Weighted average traffic in the first half was 17.5% above the same time last year
  • Statutory next profit after tax (NPAT) of $71 million, from a loss of $123 million a year ago
  • Excluding "notable items", NPAT grew by 845% year on year to $86 million from $9.1 million
  • More than $250 million in capital expenditure "delivered across all businesses" in 1H 2021
  • First half distribution guidance of 15.5 cents per security.

What happened in FY21 for Atlas Arteria?

In a positive for the Atlas Arteria share price, the company recognised a recovery in weighted average traffic volumes towards pre-pandemic levels. It recorded an approximate 18% year on year increase in traffic volumes, however, this was still about 20% below 2019 levels.

The company's APRR business grew its traffic numbers by 19% year on year, resulting in an 18.6% increase in toll revenue to $1.68 billion. This carried through to an EBITDA of $1.3 billion, which is a 23% growth on the year prior.

For its Warnow Tunnel toll road, traffic decreased almost 9% this half, which also reduced toll revenue by 7% to $8.5 million. Atlas explained that Warnow was "more significantly impacted by COVID-19" than any other site in 2020, due to a resurgence in cases there.

Furthermore, at its Dulles Greenway asset, toll revenue gained 1.8% to $34.6 million and EBITDA grew by 2% for this business also. Compared to the first half in 2019, "traffic was down 41.2%, toll revenue was down by 39.8% and EBITDA was 45.3% down".

At the end of the first half, the Dulles Greenway business had US$196.9 million in cash reserves on its balance sheet.

As a result, the company grew its overall NPAT to $86 million, an 844% growth from the year prior, although a 2.4% decrease from 2019.

Finally, there is another point that could weigh in on the Atlas Arteria share price. The company declared first-half "distribution guidance" of 15.5 cents per security, reflecting "underlying performance" of its businesses.

What did management say?

Speaking on the results, Atlas Arteria CEO Graeme Bevans said:

Our roads provide critical infrastructure that connect communities. Our European businesses have benefitted from the COVID-safe operation of French industry and growing European trade. We are well positioned to take advantage of increasing travel in response to improving vaccination levels and the new EU health pass encouraging safe mobility through the region.

Regarding the company's financial position, Bevans added:

Our balance sheets are very well positioned. At the corporate level we currently have no debt, ample liquidity, strong cash flows from APRR and Warnow Tunnel and remain well placed to pursue growth opportunities as they arise.

What's next for Atlas Arteria?

Management did not provide explicit guidance in terms of figures in its report, however, it did explain that European summer traffic "has been averaging more than 5% above 2020 and 2019 levels".

In regards to the second half of 2021, the company is "well-positioned to benefit from increased travel" as COVID-19 restrictions ease in Europe.

Other than this, Atlas seems focused on driving ESG and other sustainability initiatives throughout the coming periods.

The Atlas Arteria share price has posted a loss of 1.46% since January 1. This result had lagged the S&P/ASX 200 Index (ASX: XJO)'s return of around 14% this year to date.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Earnings Results

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Earnings Results

Westpac shares on watch amid $6.99b profit and new buyback

Has the big four bank delivered the goods for investors this year? Let's find out.

Read more »

Woman inspecting packages.
Earnings Results

This top 50 ASX stock is diving 5% despite a strong outlook

Investors were looking for more.

Read more »

Two male ASX 200 analysts stand in an office looking at various computer screens showing share prices
Earnings Results

Macquarie share price sinks despite $1.6b half year profit and new buyback

How did this investment bank perform during the first half? Let's find out.

Read more »

A woman holds her hand out under a graphic hologram image of a human brain with brightly lit segments and section points.
Earnings Results

Why the BrainChip share price is in the spotlight this week

Today's reaction is in stark contrast to the day of the release.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

2 All Ords ASX healthcare shares making BIG moves on quarterly updates

These two ASX healthcare companies are seeing heavy trading on Thursday.

Read more »

A businesswoman ponders why her boat is sinking in the ocean.
Resources Shares

Lake Resources share price sinks on quarterly cash flow news

Let's take a look at the highlights of the company's Q3 update.

Read more »

Lithium ion batteries
Earnings Results

Needs a recharge: Novonix share price sees red after Q3 earnings

Investors were likely expecting a tad more.

Read more »

chip and tech stocks represented by two computer chips side by side
AI Stocks

Up 237% in 2024, why is the Appen share price racing higher again today?

Investors are bidding up Appen shares again today. But why?

Read more »